(Reuters) - An infectious disease expert and former head dealmaker at Merck & Co is racing against his ex-employer and other drugmakers to develop a treatment for a germ that ravages the colon and kills as many as 14,000 Americans each year.
Roger Pomerantz on Monday became chief executive officer of privately held Seres Health, whose lead product has proven highly effective against the c. difficile bacteria in early-stage clinical trials.
17:46 George H.W. Bush to leave intensive care; Barbara Bush released15
16:18 The Latest: Former President George H.W. Bush leaving ICU11
11:15 One killed, 5 hospitalized in San Antonio mall robbery 'gone really, really bad'7
23:15 The Latest: George HW Bush, Barbara, in hospital overnight16